당뇨망막병증 시장 : 질환 유형별, 치료 유형별, 투여 경로별, 최종 용도별, 유통 채널별, 지역별

Global Diabetic Retinopathy Market is estimated to be valued at USD 9.91 Bn in 2025 and is expected to reach USD 15.40 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.

Figure. Diabetic Retinopathy Market Share (%), By Region 2025

Diabetic retinopathy is a medical condition in which damage occurs to the retina due to complications of diabetes mellitus. High blood sugar levels associated with diabetes can damage blood vessels inside the retina. Diabetic retinopathy occurs in both type 1 and type 2 diabetes and is a leading cause of blindness among working-age adults. The global diabetic retinopathy market is driven by rising prevalence of diabetes, increasing awareness regarding diabetic retinopathy diagnosis and treatment, and the availability of advanced retinal screening techniques. However, high cost of treatment and inadequate reimbursement policies limit the market growth.

Market Dynamics:

High cost of retinal screening, drugs, and surgeries, shortage of ophthalmologists in developing nations, and inadequate insurance coverage in some countries are expected to restrain the market growth. Key opportunity lies in development of cost-effective screening solutions, combinational therapeutics, and artificial intelligence-powered analytic platforms to detect diabetic retinopathy faster and more accurately.

Key Features of the Study:

This report provides in-depth analysis of the global diabetic retinopathy market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032, considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global diabetic retinopathy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Novartis AG, Bayer AG, Regeneron Pharmaceuticals Inc., Roche Holding AG, Allergan PLC, Zeiss International, Topcon Corporation, Heidelberg Engineering GmbH, Optos PLC, Canon Inc., Nidek Co., Ltd., Ellex Medical Lasers Limited, Bausch + Lomb Incorporated, Abbott Laboratories, and Santen Pharmaceutical Co., Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global diabetic retinopathy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

• By Disease Type Insights (Revenue, USD Bn, 2019 - 2032)
  • Proliferative Diabetic Retinopathy
  • Non-proliferative Diabetic Retinopathy
• By Treatment Type Insights (Revenue, USD Bn, 2019 - 2032)
  • Anti-Vascular Endothelial Growth Factor Therapy
  • Intraocular Steroid Injection
  • Laser Surgery
  • Vitrectomy
  • Others (Intraocular Corticosteroids, etc.)
• By Route of Administration Insights (Revenue, USD Bn, 2019 - 2032)
  • Intravitreal Injections
  • Intravitreal Implants
  • Oral
  • Topical Eye Drops
  • Laser Surgery
  • Others
• By End User Insights (Revenue, USD Bn, 2019 - 2032)
  • Hospitals
  • Ophthalmology Clinics
  • Ambulatory Surgery Centers
  • Long-Term Care Centers
  • Others
• By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2032)
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
• Regional Insights (Revenue, USD Bn, 2019 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Novartis AG
  • Bayer AG
  • Regeneron Pharmaceuticals Inc.
  • Roche Holding AG
  • Allergan PLC
  • Zeiss International
  • Topcon Corporation
  • Heidelberg Engineering GmbH
  • Optos PLC
  • Canon Inc.
  • Nidek Co., Ltd.
  • Ellex Medical Lasers Limited
  • Bausch + Lomb Incorporated
  • Abbott Laboratories
  • Santen Pharmaceutical Co., Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Diabetic Retinopathy Market, By Disease Type
  • Global Diabetic Retinopathy Market, By Treatment Type
  • Global Diabetic Retinopathy Market, By Route of Administration
  • Global Diabetic Retinopathy Market, By End User
  • Global Diabetic Retinopathy Market, By Distribution Channel
  • Global Diabetic Retinopathy Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
  • Restraint
  • Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Diabetic Retinopathy Market, By Disease Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Proliferative Diabetic Retinopathy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Non-proliferative Diabetic Retinopathy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Diabetic Retinopathy Market, By Treatment Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Anti-Vascular Endothelial Growth Factor Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Intraocular Steroid Injection
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Laser Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Vitrectomy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (Intraocular Corticosteroids, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Diabetic Retinopathy Market, By Route of Administration, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Intravitreal Injections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Intravitreal Implants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Topical Eye Drops
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Laser Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Diabetic Retinopathy Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ophthalmology Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Surgery Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Long-Term Care Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Diabetic Retinopathy Market, By Distribution Channel, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Diabetic Retinopathy Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa

10. Competitive Landscape

• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bayer AG
• Regeneron Pharmaceuticals Inc.
• Roche Holding AG
• Allergan PLC
• Zeiss International
• Topcon Corporation
• Heidelberg Engineering GmbH
• Optos PLC
• Canon Inc.
• Nidek Co., Ltd.
• Ellex Medical Lasers Limited
• Bausch + Lomb Incorporated
• Abbott Laboratories
• Santen Pharmaceutical Co., Ltd.

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us